| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $17,428,057 ) (Continued on the next page) |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL134899 | Engineering nitric oxide releasing polymer with immobilized thrombin inhibitor for blood contacting applications | 000 | 7 | NIH | 12/21/2023 | $336,767 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R25GM109435 | PREP at University of Georgia | 000 | 10 | NIH | 3/1/2024 | $343,158 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01GM111939 | Structure and Function in alpha-Dystroglycan Glycosylation | 000 | 10 | NIH | 1/17/2024 | $339,923 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | T35OD010433 | Georgia Veterinary Scholars Summer Research Program | 000 | 18 | NIH | 4/1/2024 | $61,064 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01ES033892 | Microglial Hv1 Proton Channel as a Mediator of Environmentally-Induced Neuroinflammation and Neurodegeneration | 001 | 3 | NIH | 2/14/2024 | $625,498 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R61AI169204 | Novel Nanoparticle Respiratory Tract Mucosal Vaccine | 000 | 3 | NIH | 3/15/2024 | $230,960 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R61AI169204 | Novel Nanoparticle Respiratory Tract Mucosal Vaccine | 000 | 3 | NIH | 3/15/2024 | $230,960 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01ES033892 | Microglial Hv1 Proton Channel as a Mediator of Environmentally-Induced Neuroinflammation and Neurodegeneration | 005 | 3 | NIH | 4/15/2024 | $354,264 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01ES033892 | Microglial Hv1 Proton Channel as a Mediator of Environmentally-Induced Neuroinflammation and Neurodegeneration | 005 | 3 | NIH | 4/15/2024 | $220,240 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01NS119517 | Novel Modulators of TGF?1 signaling in regulation of remyelination by neural stem cells | 001 | 3 | NIH | 2/21/2024 | $331,282 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AR078903 | Pathological Foundations of Skeletal Muscle After Volumetric Muscle Loss and Targets For Rehabilitation | 000 | 3 | NIH | 3/11/2024 | $404,739 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI162989 | Targeted Pan-Antifungal Liposomes | 000 | 3 | NIH | 1/31/2024 | $479,463 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01GM135444 | Intracellular pattern formation | 000 | 4 | NIH | 3/8/2024 | $271,800 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | DP2AI154416 | Tapeworm stem cells as drivers of regeneration and reproduction | 000 | 4 | NIH | 2/21/2024 | $407,700 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM139656 | Unlocking sequence-structure-function-disease relationships in large protein super-families | 000 | 4 | NIH | 1/23/2024 | $415,854 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01NS114567 | Precision Medicine for the Peripheral Nervous System Disorder Familiar Dysautonomia | 001 | 4 | NIH | 4/17/2024 | $26,425 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01NS114567 | Precision Medicine for the Peripheral Nervous System Disorder Familiar Dysautonomia | 000 | 4 | NIH | 11/24/2023 | $339,750 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01NS119610 | Elucidating the role of NK cells in Lewy body diseases | 000 | 4 | NIH | 4/17/2024 | $356,445 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DK124366 | Regulation of Translation by O-GlcNAc - Resubmission 03-05-2020 | 000 | 4 | NIH | 11/21/2023 | $448,029 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI148365 | Prevention and Treatment of Pneumocystis Pneumonia | 000 | 5 | NIH | 4/18/2024 | $754,801 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01GM136827 | Regulation of the Translational Response to Cellular Stress | 002 | 6 | NIH | 4/16/2024 | $272,798 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI151148 | Trypanosoma cruzi dormancy and its implications for therapeutic treatment | 000 | 5 | NIH | 2/15/2024 | $429,308 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01MH120092 | 4/5 CAPER: Computerized assessment of psychosis risk | 000 | 5 | NIH | 3/1/2024 | $363,974 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI150098 | The Cell Envelope of the Multi-Drug Resistant Pathogen Acinetobacter baumannii | 000 | 5 | NIH | 1/4/2024 | $485,390 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI146857 | Dual oxidase and lactoperoxidase in influenza infection | 000 | 5 | NIH | 1/19/2024 | $339,750 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM128620 | Biosensor-driven Platforms for Biosynthesis of Natural Products in Bacteria | 004 | 6 | NIH | 4/8/2024 | $8,599 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI175925 | Development of ganglioside specific IgGs for the treatment of Guillian-Barr? Syndrome | 000 | 1 | NIH | 2/19/2024 | $206,098 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31MH134508 | Exploring the Effects of Childhood Maltreatment on Inflammation and Major Depression: From Adolescence to Middle Adulthood | 000 | 1 | NIH | 2/29/2024 | $42,048 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21HL168507 | A deep learning-enhanced multiphysics and multiscale framework for predictive modeling of inflammation-induced thrombosis | 000 | 1 | NIH | 1/25/2024 | $221,902 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI158743 | Synthetic multi-component influenza vaccines to elicit broad immunity | 000 | 1 | NIH | 12/19/2023 | $598,520 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI183057 | The cystic fibrosis sputum compromises the ability of neutrophils to kill Staphylococcus aureus | 000 | 1 | NIH | 3/7/2024 | $167,482 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL172496 | Nitric Oxide Functionalized Antibiotics to Combat Infections and Thrombosis for Extracorporeal Life Support | 000 | 1 | NIH | 1/25/2024 | $447,161 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM153189 | Analysis of Metabolic Stress and Functional Integration in Prokaryotes | 000 | 1 | NIH | 3/25/2024 | $252,429 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM152057 | Regulation of protein transport in cilia | 000 | 1 | NIH | 12/8/2023 | $343,477 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | K01DA059329 | Trauma-informed, resilience-based telehealth intervention for improving HIV prevention and HCV care for persons who inject drugs in the Deep South | 000 | 1 | NIH | 1/30/2024 | $178,024 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31AI181461 | Understanding Plasmodium falciparum's multidrug resistance protein through the characterization of a novel antimalarial class. | 000 | 1 | NIH | 12/8/2023 | $47,694 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AT012783 | Multi-omics approaches to lower the barriers to sustainable production of plant natural products with relevance to human health | 000 | 1 | NIH | 2/21/2024 | $529,426 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI173084 | Epitope and mechanistic correlates of broadly protective human antibodies for pneumococcal infection | 000 | 2 | NIH | 11/1/2023 | $653,539 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI176776 | Synthesis and transport of outer membrane components across the Gram-negative cell envelope | 000 | 2 | NIH | 12/14/2023 | $595,384 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM148240 | Platform for in vivo Metabolism | 000 | 2 | NIH | 1/18/2024 | $368,242 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | D43TW012481 | Digital Mobile Technologies to study Tuberculosis: A Multi-disciplinary Program | 000 | 2 | NIH | 12/10/2023 | $188,034 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | D43TW012481 | Digital Mobile Technologies to study Tuberculosis: A Multi-disciplinary Program | 000 | 2 | NIH | 12/10/2023 | $50,000 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI174600 | Divergent Calcium Channels of the Apicomplexan parasite Toxoplasma gondii | 000 | 2 | NIH | 1/17/2024 | $540,003 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31HD108843 | Utilizing Causal X-Linked Intellectual Disability Variants to Gain Insight into the O-GlcNAc Transferase Enzyme | 000 | 2 | NIH | 12/19/2023 | $47,694 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM148433 | O-glycosylation of cysteine-rich modules | 001 | 2 | NIH | 12/8/2023 | -$394,110 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM148433 | O-glycosylation of cysteine-rich modules | 001 | 2 | NIH | 12/8/2023 | $394,110 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01GM147312 | Functional Analysis of the Anti-M?llerian Hormone as a Convergently Acquired Master Sex Determination Gene | 000 | 2 | NIH | 2/27/2024 | $280,114 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM148433 | O-glycosylation of cysteine-rich modules | 000 | 2 | NIH | 11/14/2023 | $394,110 |
| | 2024 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI171727 | The activation of benzoxaborole prodrug AN15368, a clinical candidate for Chagas disease | 000 | 2 | NIH | 1/24/2024 | $169,875 |
|
